DG vs ESPR · P/E 15, rev $40.61B vs rev $332.3M
Dollar General Corporation (DG) versus Esperion Therapeutics Inc (ESPR) — a side-by-side from cached financials, not a winner call.
Dollar General Corporation (DG) is a discount stores company listed on US.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported DG revenue for 2025-01-31 was $40.61B. Net income was $1.13B. Revenue was up 5.0% from 2024-02-02 to 2025-01-31. DG currently screens at market cap $22.87B and trailing P/E 14.7.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
DG currently screens at market cap $22.87B and trailing P/E 14.7. ESPR currently screens at market cap $816.9M.
Not investment advice. Open the DG and ESPR stock pages for the full models.
Not investment advice.